
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
Surenano arranges $1.25-million private placement
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
Pharmacorp Rx arranges $15-million financing
SureNano Announces Private Placement
Ocumetics Lens shows early vision gains in trials
DRI Healthcare Reports Third Quarter 2025 Results
PharmaCorp Announces C$15 Million Bought Deal Public Offering
Cardiol's Archer data to be presented Nov. 29
Bausch's OraPharma expands into Canada, Puerto Rico
Appili Therapeutics arranges $750,000 private placement
Microbix faces ransomware attack, says no ops impact
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases